What is the current valuation of the Blood Group Typing Market?

As of 2024, the Blood Group Typing Market was valued at approximately 2493.86 USD Million. Read More

What is the projected market size by 2035?

The Blood Group Typing Market is projected to reach around 6371.87 USD Million by 2035. Read More

What is the expected CAGR for the market during the forecast period?

The expected CAGR for the Blood Group Typing Market from 2025 to 2035 is 8.9%. Read More

Which companies are considered key players in the Blood Group Typing Market?

Key players in the Blood Group Typing Market include Roche Diagnostics, Abbott Laboratories, Grifols S.A., and Thermo Fisher Scientific. Read More

What are the primary applications of blood group typing?

The primary applications include blood donation, transfusion, organ transplantation, paternity testing, and disease diagnosis. Read More

How does the market segment by end use?

The market segments by end use include hospitals, blood banks, diagnostic laboratories, research institutions, and home care. Read More

What technologies are utilized in blood group typing?

Technologies used in blood group typing encompass serological testing, molecular testing, microarray technology, and point of care testing. Read More

What product types are available in the market?

Product types in the market include reagents, kits, instruments, software, and consumables. Read More

What testing methods are employed in blood group typing?

Testing methods include manual testing, automated testing, rapid testing, gel testing, and microplate testing. Read More

What is the market outlook for blood banks within the Blood Group Typing Market?

Blood banks are projected to grow from 800.0 USD Million in 2024 to approximately 2100.0 USD Million by 2035. Read More

Blood Group Typing Market

ID: MRFR/MED/4949-HCR

90 Pages

Rahul Gotadki

Last Updated: April 15, 2026

Blood Group Typing Market Research Report: Size, Share, Trend Analysis By Technology (Molecular Typing, Serological Typing, Microarray-based Typing, Next-generation Sequencing), By Product Type (Reagents, Instruments, Software, Consumables), By Applications (Transfusion Medicine, Transplantation, Forensic Science, Research), By End Use (Blood Banks, Hospitals, Diagnostic Laboratories, Academic Institutions) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Blood Group Typing Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.9%

2024 Market Size$ 2,493.86 Million

2025 Market Size$ 2,715.86 Million

2035 Market Size$ 6,371.87 Million

Key Players

Companies such as Roche Diagnostics

Abbott Laboratories

Grifols S.A.

Thermo Fisher Scientific

Bio-Rad Laboratories

Ortho Clinical Diagnostics

Trends

Technological Advancements
Growing Awareness of Blood Safety
Integration of Artificial Intelligence

Opportunities

Increase in Surgical Procedures
Growing Awareness of Blood Donation
Regulatory Support for Blood Safety

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Blood Donation | |
  2. 4.1.2 Transfusion | |
  3. 4.1.3 Organ Transplantation | |
  4. 4.1.4 Paternity Testing | |
  5. 4.1.5 Disease Diagnosis |
2. 4.2 Healthcare, BY End Use (USD Million) | |
  1. 4.2.1 Hospitals | |
  2. 4.2.2 Blood Banks | |
  3. 4.2.3 Diagnostic Laboratories | |
  4. 4.2.4 Research Institutions | |
  5. 4.2.5 Home Care |
3. 4.3 Healthcare, BY Technology (USD Million) | |
  1. 4.3.1 Serological Testing | |
  2. 4.3.2 Molecular Testing | |
  3. 4.3.3 Microarray Technology | |
  4. 4.3.4 Next Generation Sequencing | |
  5. 4.3.5 Point of Care Testing |
4. 4.4 Healthcare, BY Product Type (USD Million) | |
  1. 4.4.1 Reagents | |
  2. 4.4.2 Kits | |
  3. 4.4.3 Instruments | |
  4. 4.4.4 Software | |
  5. 4.4.5 Consumables |
5. 4.5 Healthcare, BY Testing Method (USD Million) | |
  1. 4.5.1 Manual Testing | |
  2. 4.5.2 Automated Testing | |
  3. 4.5.3 Rapid Testing | |
  4. 4.5.4 Gel Testing | |
  5. 4.5.5 Microplate Testing |
6. 4.6 Healthcare, BY Region (USD Million) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Roche Diagnostics (CH) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Abbott Laboratories (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Grifols S.A. (ES) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Thermo Fisher Scientific (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Bio-Rad Laboratories (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Ortho Clinical Diagnostics (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Danaher Corporation (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Merck KGaA (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Becton, Dickinson and Company (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY END USE |
8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 US MARKET ANALYSIS BY PRODUCT TYPE |
10. 6.7 US MARKET ANALYSIS BY TESTING METHOD |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
12. 6.9 CANADA MARKET ANALYSIS BY END USE |
13. 6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY |
14. 6.11 CANADA MARKET ANALYSIS BY PRODUCT TYPE |
15. 6.12 CANADA MARKET ANALYSIS BY TESTING METHOD |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
18. 6.15 GERMANY MARKET ANALYSIS BY END USE |
19. 6.16 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
20. 6.17 GERMANY MARKET ANALYSIS BY PRODUCT TYPE |
21. 6.18 GERMANY MARKET ANALYSIS BY TESTING METHOD |
22. 6.19 UK MARKET ANALYSIS BY APPLICATION |
23. 6.20 UK MARKET ANALYSIS BY END USE |
24. 6.21 UK MARKET ANALYSIS BY TECHNOLOGY |
25. 6.22 UK MARKET ANALYSIS BY PRODUCT TYPE |
26. 6.23 UK MARKET ANALYSIS BY TESTING METHOD |
27. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION |
28. 6.25 FRANCE MARKET ANALYSIS BY END USE |
29. 6.26 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
30. 6.27 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
31. 6.28 FRANCE MARKET ANALYSIS BY TESTING METHOD |
32. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION |
33. 6.30 RUSSIA MARKET ANALYSIS BY END USE |
34. 6.31 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
35. 6.32 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE |
36. 6.33 RUSSIA MARKET ANALYSIS BY TESTING METHOD |
37. 6.34 ITALY MARKET ANALYSIS BY APPLICATION |
38. 6.35 ITALY MARKET ANALYSIS BY END USE |
39. 6.36 ITALY MARKET ANALYSIS BY TECHNOLOGY |
40. 6.37 ITALY MARKET ANALYSIS BY PRODUCT TYPE |
41. 6.38 ITALY MARKET ANALYSIS BY TESTING METHOD |
42. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION |
43. 6.40 SPAIN MARKET ANALYSIS BY END USE |
44. 6.41 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
45. 6.42 SPAIN MARKET ANALYSIS BY PRODUCT TYPE |
46. 6.43 SPAIN MARKET ANALYSIS BY TESTING METHOD |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY TESTING METHOD |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY APPLICATION |
54. 6.51 CHINA MARKET ANALYSIS BY END USE |
55. 6.52 CHINA MARKET ANALYSIS BY TECHNOLOGY |
56. 6.53 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
57. 6.54 CHINA MARKET ANALYSIS BY TESTING METHOD |
58. 6.55 INDIA MARKET ANALYSIS BY APPLICATION |
59. 6.56 INDIA MARKET ANALYSIS BY END USE |
60. 6.57 INDIA MARKET ANALYSIS BY TECHNOLOGY |
61. 6.58 INDIA MARKET ANALYSIS BY PRODUCT TYPE |
62. 6.59 INDIA MARKET ANALYSIS BY TESTING METHOD |
63. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION |
64. 6.61 JAPAN MARKET ANALYSIS BY END USE |
65. 6.62 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
66. 6.63 JAPAN MARKET ANALYSIS BY PRODUCT TYPE |
67. 6.64 JAPAN MARKET ANALYSIS BY TESTING METHOD |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY TESTING METHOD |
73. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION |
74. 6.71 MALAYSIA MARKET ANALYSIS BY END USE |
75. 6.72 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
76. 6.73 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE |
77. 6.74 MALAYSIA MARKET ANALYSIS BY TESTING METHOD |
78. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION |
79. 6.76 THAILAND MARKET ANALYSIS BY END USE |
80. 6.77 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
81. 6.78 THAILAND MARKET ANALYSIS BY PRODUCT TYPE |
82. 6.79 THAILAND MARKET ANALYSIS BY TESTING METHOD |
83. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION |
84. 6.81 INDONESIA MARKET ANALYSIS BY END USE |
85. 6.82 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
86. 6.83 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE |
87. 6.84 INDONESIA MARKET ANALYSIS BY TESTING METHOD |
88. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION |
89. 6.86 REST OF APAC MARKET ANALYSIS BY END USE |
90. 6.87 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
91. 6.88 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE |
92. 6.89 REST OF APAC MARKET ANALYSIS BY TESTING METHOD |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION |
95. 6.92 BRAZIL MARKET ANALYSIS BY END USE |
96. 6.93 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
97. 6.94 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE |
98. 6.95 BRAZIL MARKET ANALYSIS BY TESTING METHOD |
99. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION |
100. 6.97 MEXICO MARKET ANALYSIS BY END USE |
101. 6.98 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
102. 6.99 MEXICO MARKET ANALYSIS BY PRODUCT TYPE |
103. 6.100 MEXICO MARKET ANALYSIS BY TESTING METHOD |
104. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION |
105. 6.102 ARGENTINA MARKET ANALYSIS BY END USE |
106. 6.103 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
107. 6.104 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE |
108. 6.105 ARGENTINA MARKET ANALYSIS BY TESTING METHOD |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHOD |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHOD |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHOD |
125. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION |
126. 6.123 REST OF MEA MARKET ANALYSIS BY END USE |
127. 6.124 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
128. 6.125 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE |
129. 6.126 REST OF MEA MARKET ANALYSIS BY TESTING METHOD |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
138. 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million) |
140. 6.137 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
142. 6.139 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million) |
144. 6.141 HEALTHCARE, BY TESTING METHOD, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY TESTING METHOD, 2024 TO 2035 (USD Million) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.2.5 BY TESTING METHOD, 2025-2035 (USD Million) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.3.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.3.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.3.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.3.5 BY TESTING METHOD, 2025-2035 (USD Million) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.4.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.4.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.4.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.4.5 BY TESTING METHOD, 2025-2035 (USD Million) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.5.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.5.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.5.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.5.5 BY TESTING METHOD, 2025-2035 (USD Million) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.6.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.6.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.6.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.6.5 BY TESTING METHOD, 2025-2035 (USD Million) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.7.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.7.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.7.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.7.5 BY TESTING METHOD, 2025-2035 (USD Million) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.8.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.8.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.8.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.8.5 BY TESTING METHOD, 2025-2035 (USD Million) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.9.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.9.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.9.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.9.5 BY TESTING METHOD, 2025-2035 (USD Million) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.10.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.10.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.10.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.10.5 BY TESTING METHOD, 2025-2035 (USD Million) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.11.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.11.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.11.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.11.5 BY TESTING METHOD, 2025-2035 (USD Million) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.12.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.12.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.12.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.12.5 BY TESTING METHOD, 2025-2035 (USD Million) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.13.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.13.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.13.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.13.5 BY TESTING METHOD, 2025-2035 (USD Million) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.14.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.14.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.14.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.14.5 BY TESTING METHOD, 2025-2035 (USD Million) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.15.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.15.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.15.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.15.5 BY TESTING METHOD, 2025-2035 (USD Million) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.16.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.16.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.16.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.16.5 BY TESTING METHOD, 2025-2035 (USD Million) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.17.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.17.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.17.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.17.5 BY TESTING METHOD, 2025-2035 (USD Million) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.18.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.18.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.18.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.18.5 BY TESTING METHOD, 2025-2035 (USD Million) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.19.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.19.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.19.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.19.5 BY TESTING METHOD, 2025-2035 (USD Million) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.20.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.20.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.20.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.20.5 BY TESTING METHOD, 2025-2035 (USD Million) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.21.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.21.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.21.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.21.5 BY TESTING METHOD, 2025-2035 (USD Million) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.22.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.22.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.22.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.22.5 BY TESTING METHOD, 2025-2035 (USD Million) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.23.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.23.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.23.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.23.5 BY TESTING METHOD, 2025-2035 (USD Million) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.24.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.24.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.24.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.24.5 BY TESTING METHOD, 2025-2035 (USD Million) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.25.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.25.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.25.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.25.5 BY TESTING METHOD, 2025-2035 (USD Million) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.26.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.26.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.26.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.26.5 BY TESTING METHOD, 2025-2035 (USD Million) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.27.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.27.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.27.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.27.5 BY TESTING METHOD, 2025-2035 (USD Million) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.28.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.28.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.28.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.28.5 BY TESTING METHOD, 2025-2035 (USD Million) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.29.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.29.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.29.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.29.5 BY TESTING METHOD, 2025-2035 (USD Million) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.30.2 BY END USE, 2025-2035 (USD Million) | |
  3. 7.30.3 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  4. 7.30.4 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  5. 7.30.5 BY TESTING METHOD, 2025-2035 (USD Million) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Blood Group Typing Market Segmentation

Blood Group Typing Market By Application (USD Million, 2025-2035)

Blood Donation
Transfusion
Organ Transplantation
Paternity Testing
Disease Diagnosis

Blood Group Typing Market By End Use (USD Million, 2025-2035)

Hospitals
Blood Banks
Diagnostic Laboratories
Research Institutions
Home Care

Blood Group Typing Market By Blood Group Typing Market (USD Million, 2025-2035)

Serological Testing
Molecular Testing
Microarray Blood Group Typing Market
Next Generation Sequencing
Point of Care Testing

Blood Group Typing Market By Product Type (USD Million, 2025-2035)

Reagents
Kits
Instruments
Software
Consumables

Blood Group Typing Market By Testing Method (USD Million, 2025-2035)

Manual Testing
Automated Testing
Rapid Testing
Gel Testing
Microplate Testing

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”